Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Dermatitis: early-phase trial registry
2 of 7 indexed Dermatitis trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #2,497 of 28,707 conditions by registered trial count.
7 US clinical trials · 2 currently recruiting · #2,497 of 28,707 conditions by registered trial count
Dermatitis: 7 US clinical trials tracked, 2 recruiting.
Dermatitis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 2 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most active sponsor is Kimberly-Clark Corporation, running 1 of these trials.
Enrollment posture brief
Registry condition dermatitis
OPEN 2 | RECR 29% | LATE 0 | EARLY 4 | RANK #2497 | SPON 1
Volume-matched condition peers
Nearest open-share peer: Acromegaly (29% recruiting · 14 trials)
Dermatitis lists 2 open slots (29% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Dermatitis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Dermatitis is recruiting below its size-band peers.
2 of 7 indexed trials (28.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Dermatitis trials is spread across many organizations.
Kimberly-Clark Corporation accounts for 1 of 7 trials (14.3%). 7 distinct sponsors appear on at least one study for this condition label.
-
Typical Dermatitis enrolment sits around 96 participants.
Median target enrolment is 96 among the 7 trials that report a genuine target (sentinel values excluded). 4 of those (57.1%) plan for fewer than 100 participants.
-
Dermatitis research is mostly interventional.
5 interventional and 2 observational studies make up this index (71.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
7 total, page 1 of 1
Effects of Treatments on Atopic Dermatitis
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
NCT01631617
ATI-045 Versus Placebo in Patients With Moderate-to-Severe Atopic Dermatitis
Aclaris Therapeutics
NCT07011706
Assessment of Digital Imaging as a Tool for Diagnosing Psoriasis, Hand Rashes and Unusual Moles
National Cancer Institute (NCI)
NCT00005781
A Study to Evaluate Risankizumab in Adults and Adolescents With Moderate to Severe Atopic Dermatitis
AbbVie
NCT03706040
Sequential Ascending Dose Study to Assess the Safety and Tolerability of REGN668 (SAR231893) in Patients With Atopic Dermatitis
Regeneron Pharmaceuticals
NCT01259323
Infant Fecal Insult Study
Kimberly-Clark Corporation
NCT02979210
Evaluating for Contact Allergies in Patients With Chronic Urticaria
Tufts Medical Center
NCT00868036
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 1 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Dermatitis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Dermatitis trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Dermatitis page
7 registered trials, 2 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 2 Dermatitis trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Kimberly-Clark Corporation sponsors the most Dermatitis trials on record, review their full trial history before evaluating a specific study. See Kimberly-Clark Corporation's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Dermatitis condition card totals 7 registered trials; most-linked intervention REGN668; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.